Baumer S.A. (BVMF:BALM3)
Brazil
· Delayed Price · Currency is BRL 22.50
+1.60 (7.66%)
At close: Nov 13, 2025
Baumer Revenue
Baumer had revenue of 55.03M BRL in the quarter ending September 30, 2025, with 1.60% growth. This brings the company's revenue in the last twelve months to 219.24M, up 22.81% year-over-year. In the year 2024, Baumer had annual revenue of 194.39M with 14.38% growth.
Revenue (ttm)
219.24M
Revenue Growth
+22.81%
P/S Ratio
0.91
Revenue / Employee
716.46K
Employees
306
Market Cap
200.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 194.39M | 24.44M | 14.38% |
| Dec 31, 2023 | 169.95M | 5.41M | 3.29% |
| Dec 31, 2022 | 164.54M | 30.72M | 22.96% |
| Dec 31, 2021 | 133.82M | -29.15M | -17.89% |
| Dec 31, 2020 | 162.97M | 13.66M | 9.15% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 54.20B |
| Raia Drogasil | 42.23B |
| Hypera | 6.97B |
| Fleury | 8.07B |
| Odontoprev | 2.53B |
| Diagnósticos da América | 12.57B |
| Empreendimentos Pague Menos | 14.27B |
| Blau Farmacêutica | 1.77B |